Free Online CME

Renal Cell Carcinoma Update:
Multidisciplinary Management Strategies
to Enhance Patient Outcomes
Webcast Series

In the United States, renal cell carcinoma (RCC) is diagnosed in approximately 60,000 patients each year and accounts for 90% of all kidney cancers. The disease can often be successfully treated if it is diagnosed in the early stages; however, advanced disease 5-year survival rates are as low as 10%. A recent increase in research on the pathophysiologic mechanism of renal cell cancer has led to a shift in management approaches that improve survival rates. In the webcast series, Renal Cell Carcinoma, expert faculty will provide evidence-based recommendations that synthesize current advances and data into clinical practices that improve the screening, diagnosis, treatment, and overall care of this patient population.

This activity has expired.
You will be redirected to this specialty page to find related content.